References
- Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997; 25(3):541–7
- Krawitt EL. Autoimmune hepatitis. N Engl] Med 1996; 334(14):897–903
- Zauli D, Ghetti S, Grassi A, et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 1997; 25(5):1105–7
- Batts KP, Ludwig J. Histopathology of autoimmune chronic active hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. In: Krawitt EL, Wiesner RH. Autoimmune liver diseases. New York: Raven Press, 1991: 75–92
- Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996; 110(3):848–57
- Czaja AJ. Low-dose corticosteroid therapy after multiple relapses of severe HBs Ag-negative chronic active hepatitis. Hepatology 1990; 11(6):1044–9
- Pratt DS, Flavin DP, Kaplan MM. The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 1996; 110(1):271–4
- Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333(15):958–63